🇺🇸 FDA
Company

ARROWHEAD

ARROWHEAD PHARMACEUTICALS, INC.

ARWR pharma USA

Quick answer

ARROWHEAD is a pharma company (ARWR) headquartered in PASADENA, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Calcium carbonate

Uterine Contraction

Phase 3 · small_molecule · completed

1 trials project

Plozasiran

Severe Hypertriglyceridemia

Phase 3 · small_molecule · active

1 trials project

Plozasiran

Familial Chylomicronemia

Phase 3 · small_molecule · active

1 trials project

Plozasiran

Familial Chylomicronemia Syndrome

Phase 3 · small_molecule · completed

1 trials project

Plozasiran Injection

Severe Hypertriglyceridemia

Phase 3 · small_molecule · active

2 trials project

Plozasiran Injection

Hypertriglyceridemia

Phase 3 · small_molecule · active

2 trials project

Statins

Intracerebral Hemorrhage

Phase 3 · small_molecule · active

1 trials project

Tranexamic Acid

Hemorrhagic Shock

Phase 3 · small_molecule · completed

1 trials project

Venofer 200 MG Per 10 ML Injection

Iron Deficiency Anemia of Pregnancy

Phase 3 · small_molecule · active

1 trials project

Zodasiran

Homozygous Familial Hypercholesterolemia

Phase 3 · small_molecule · active

1 trials project

zodasiran Injection

Homozygous Familial Hypercholesterolemia

Phase 3 · small_molecule · active

1 trials project

ARC-520

Hepatitis B, Chronic

Phase 2 · small_molecule · terminated

1 trials project

ARC-520

Chronic Hepatitis B

Phase 2 · small_molecule · terminated

1 trials project

ARC-520

Hepatitis B

Phase 2 · small_molecule · terminated

2 trials project

ARC-520 Injection

Hepatitis B

Phase 2 · small_molecule · terminated

2 trials project

ARC-520 Injection

Chronic Hepatitis B

Phase 2 · small_molecule · terminated

1 trials project

ARC-AAT Injection

Alpha-1 Antitrypsin Deficiency

Phase 2 · small_molecule · terminated

2 trials project

ARO-AAT

Alpha 1-Antitrypsin Deficiency

Phase 2 · small_molecule · completed

1 trials project

ARO-ALK7

Obesity

Phase 2 · small_molecule · active

1 trials project

ARO-ANG 3 Injection

Homozygous Familial Hypercholesterolemia

Phase 2 · small_molecule · terminated

1 trials project

ARO-ANG3

Mixed Dyslipidemia

Phase 2 · small_molecule · completed

1 trials project

ARO-APOC3

Severe Hypertriglyceridemia

Phase 2 · small_molecule · completed

1 trials project

ARO-APOC3

Mixed Dyslipidemia

Phase 2 · small_molecule · completed

1 trials project

ARO-APOC3

Dyslipidemias

Phase 2 · small_molecule · completed

1 trials

Drugs (1)

drug

plozasiran sodium

REDEMPLO

Patents (8)

patent

US 12378558

RNAi agents for inhibiting expression of complement factor B (CFB), pharmaceutic

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12365897

RNAi agents for inhibiting expression of mucin 5AC (MUC5AC), compositions thereo

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12365899

RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12221610

RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions there

Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12188017

Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin

Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12173086

Alpha-v beta-6 integrin ligands and uses thereof

Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12116573

Targeting ligands for therapeutic compounds

Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12110492

RNAi agents for inhibiting expression of complement component C3 (C3), pharmaceu

Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)